+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Pet Health News How Elanco Animal Health Incorporated Elan Is The Best Small Cap Value Stock To Buy According To Hedge Funds is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Pet Health News How Elanco Animal Health Incorporated Elan Is The Best Small Cap Value Stock To Buy According To Hedge Funds | RobinsPost News & Noticias

Elanco Animal Health Q2: Rising Innovation Revenue, Initiate At Buy


I rate Elanco Animal Health Incorporated shares a Buy with a $20 fair value, driven by strong innovation and recent operational improvements. Elanco's focus on innovative products like Zenrelia and ... Read More

Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates


Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.3 per share a year ... Read More

Elanco Animal Health Incorporated (ELAN) Q2 2025 Earnings Call Transcript


Ladies and gentlemen, thank you for standing by. Welcome to Elanco Animal Health Second Quarter 2025 Earnings Conference Call. [Operator Instructions] I would now like to hand the call over to Tiffany ... Read More

Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook


Elanco posted Q2 sales of $1.24 billion, beating estimates and growing 5% YoY; adjusted EPS was $0.26, down 13% YoY. Pet Health revenue rose 11% to $643 million; Seresto and Advantage lines ... Read More

Elanco Animal Health (ELAN) Reports Q2 Earnings: What Key Metrics Have to Say


Elanco Animal Health Incorporated (ELAN) reported $1.24 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 4.8%. EPS of $0.26 for the same period compares to ... Read More

Why Elanco (ELAN) Stock Is Trading Lower Today


What Happened? Shares of animal health company Elanco (NYSE:ELAN) fell 4.1% in the afternoon session after competitor Boehringer Ingelheim announced the U.S. launch of a new, advanced vaccine for ... Read More

5 Analysts Have This To Say About Elanco Animal Health


Elanco Animal Health ELAN has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings, ... Read More

Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600


NEW YORK, Aug. 26, 2025 /PRNewswire/ -- Elanco Animal Health Inc. (NYSE: ELAN) will replace Sarepta Therapeutics Inc. (NASD: SRPT) in the S&P MidCap 400, and Sarepta Therapeutics will replace ... Read More

Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook


Elanco Animal Health Incorporated (NYSE:ELAN) reported second-quarter 2025 results on Thursday, posting adjusted earnings per share of 26 cents, down 13% year over year. Despite the decline, earnings ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus